Lumiwell-AT Tablet
Marketer
Wellmark Lifesciences Private Limited
Salt Composition
Artemether (80mg) + Lumefantrine (480mg)
Overview Lumiwell-AT Tablet
Malarone-AT tablets effectively treat malaria in patients of all ages. This combination medication, comprising two antimalarial drugs, targets the malaria parasite, halting its proliferation. It is not suitable for malaria prevention or for managing severe cases involving organ complications (brain, lungs, or kidneys). Optimal absorption requires ingestion with food. Always adhere to your physician's prescribed dosage and duration; exceeding the recommended dose may prove detrimental. Complete the entire course for thorough infection eradication. Common side effects include headache, decreased appetite, fatigue, arthralgia, and myalgia; dizziness may also occur. Report persistent or worsening symptoms to your doctor. Disclose all current medications to your doctor prior to commencing treatment. Pregnant or lactating individuals should only use this medication under strict medical supervision due to potential harm to the fetus or infant.
Uses of Lumiwell-AT Tablet
Managing Malaria Infections
Major Benefits of Lumiwell-AT Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Lumiwell-AT Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
Common Side effects of Lumiwell-AT Tablet:
- Headache
- Loss of appetite
- Dizziness
- Weakness
- Joint pain
- Muscle pain
How to use Lumiwell-AT Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the Lumiwell-AT Tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.
How Lumiwell-AT Tablet works:
Artemether and lumefantrine, the active components of Lumiwell-AT tablets, combat malaria through a synergistic antiparasitic action. The drugs' mechanism involves elevating blood heme concentrations, a process toxic to the malaria parasite, thereby eliminating the infection.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Lumiwell-AT Tablets hasn't been established as safe. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Lumiwell-AT Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Lumiwell-AT tablets while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingUNSAFE
Taking Lumiwell-AT Tablets may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these side effects.
KidneyCAUTION
Exercise caution when administering Lumiwell-AT Tablets to individuals with severely impaired renal function. Dosage modification for Lumiwell-AT Tablets might be necessary; physician consultation is advised. Severe kidney disease does not necessitate dosage alteration.
LiverCAUTION
Exercise caution when prescribing Lumiwell-AT Tablets to individuals with advanced hepatic impairment. Dosage modification might be necessary; physician consultation is advised. Severe hepatic dysfunction does not necessitate dosage alteration.
What if you forget to take Lumiwell-AT Tablet :
Should you forget a Lumiwell-AT Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Lumiwell-AT Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimalarial Drugs |
3,018 People bought this recently